日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetics, Pharmacodynamics, Efficacy and Drug Resistance Selection of Injectable Long‐Acting Lenacapavir Pre‐Exposure Prophylaxis (PrEP) Against HIV

注射用长效利那卡帕韦暴露前预防(PrEP)抗HIV的药代动力学、药效学、疗效和耐药性选择

Goulooze, Sebastiaan Camiel; Snelder, Nelleke; Eissing, Thomas; Garmann, Dirk; Kim, Hee‐yeong; Liebenberg, Antonia; Zhang, Lanxin; von Kleist, Max

Tutorial on Causal Mediation Analysis for Pharmacometricians

药物计量学家因果中介分析教程

Goulooze, Sebastiaan Camiel; Marostica, Eleonora; Snelder, Nelleke

Time-varying covariates, overadjustment bias and mediation in pharmacokinetic/pharmacodynamic modeling

药代动力学/药效动力学模型中的时变协变量、过度调整偏差和中介效应

Goulooze, Sebastiaan Camiel; Snelder, Nelleke

Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria

FIDELIO-DKD III期研究中非奈利酮剂量-暴露-血清钾反应分析:给药、滴定和入组标准的作用

Goulooze, Sebastiaan Camiel; Snelder, Nelleke; Seelmann, Andreas; Horvat-Broecker, Andrea; Brinker, Meike; Joseph, Amer; Garmann, Dirk; Lippert, Joerg; Eissing, Thomas

Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD

非甾体类盐皮质激素受体拮抗剂非奈利酮对尿白蛋白/肌酐比值 (UACR) 和估算肾小球滤过率 (eGFR) 的剂量-暴露-反应分析:来自 FIDELIO-DKD 研究的分析

Goulooze, Sebastiaan Camiel; Heerspink, Hiddo J L; van Noort, Martijn; Snelder, Nelleke; Brinker, Meike; Lippert, Joerg; Eissing, Thomas